List of bibliographic references indexed by entacapone
Number of relevant bibliographic references: 17.
| Ident. | Authors (with country if any) | Title |
|---|
| 000328 (2011) |
F. Stocchi [Italie] ; J. M. Rabey [Israël] | Effect of rasagiline as adjunct therapy to levodopa on severity of OFF in Parkinson’s disease |
| 000B04 (2009) |
H. Nissinen [Finlande] ; M. Kuoppam Ki [Finlande] ; M. Leinonen [Suède] ; A. H. Schapira [Royaume-Uni] | Early versus delayed initiation of entacapone in levodopa‐treated patients with Parkinson’s disease: a long‐term, retrospective analysis |
| 000B07 (2009) |
Robert A. Hauser [États-Unis] ; Michel Panisset [Canada] ; Giovanni Abbruzzese [Italie] ; Linda Mancione [États-Unis] ; Nalina Dronamraju [États-Unis] ; Algirdas Kakarieka [Suisse] | Double‐blind trial of levodopa/carbidopa/entacapone versus levodopa/carbidopa in early Parkinson's disease |
| 000C72 (2008) |
G. Linazasoro [Espagne] ; J. Kulisevsky [Espagne] ; B. Hernández [Espagne] | Should levodopa dose be reduced when switched to stalevo? |
| 000D62 (2008) |
P. Damier [France] ; F. Viallet [France] ; M. Ziegler [France] ; I. Bourdeix [France] ; K. Rerat [France] | Levodopa/DDCI and entacapone is the preferred treatment for Parkinson’s disease patients with motor fluctuations in routine practice: a retrospective, observational analysis of a large French cohort |
| 000E57 (2008) |
L. Bet [Italie] ; S. R. Bareggi [Italie] ; F. Pacei [Italie] ; G. Bondiolotti [Italie] ; G. Meola [Italie] ; A. H. V. Schapira [Royaume-Uni] | Bimodal administration of entacapone in Parkinson’s disease patients improves motor control |
| 001023 (2007) |
F. Grandas [Espagne] ; B. Hernández [Espagne] | Long‐term effectiveness and quality of life improvement in entacapone‐treated Parkinson's disease patients: the effects of an early therapeutic intervention |
| 001058 (2007) |
| Entacapone to tolcapone switch: Multicenter double‐blind, randomized, active‐controlled trial in advanced Parkinson's disease |
| 001462 (2005) |
Lance A. Smith [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Ghassan Al-Barghouthy [Royaume-Uni] ; Sarah Rose [Royaume-Uni] ; Mikko Kuoppamaki [Royaume-Uni, États-Unis] ; Warren Olanow [Finlande] ; Peter Jenner [Royaume-Uni] | Multiple small doses of levodopa plus entacapone produce continuous dopaminergic stimulation and reduce dyskinesia induction in MPTP‐treated drug‐naïve primates |
| 001539 (2005) |
Guowei Huang [Canada, République populaire de Chine] ; Magdalena Dragan [Canada] ; David Freeman [Canada] ; John X. Wilson [Canada, États-Unis] | Activation of catechol‐O‐methyltransferase in astrocytes stimulates homocysteine synthesis and export to neurons |
| 001579 (2004) |
Jan C. M. Zijlmans [Royaume-Uni, Pays-Bas] ; Berengere Debilly [France] ; Olivier Rascol [France] ; Andrew Lees (neurologue) [Royaume-Uni] ; Franck Durif [France] | Safety of entacapone and apomorphine coadministration in levodopa‐treated Parkinson's disease patients: Pharmacokinetic and pharmacodynamic results of a multicenter, double‐blind, placebo‐controlled, cross‐over study |
| 001774 (2003) |
D J Brooks [Royaume-Uni] ; H. Sagar [Royaume-Uni] | Entacapone is beneficial in both fluctuating and non-fluctuating patients with Parkinson’s disease: a randomised, placebo controlled, double blind, six month study |
| 001778 (2003) |
Lance A. Smith [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Matthew J. Hansard [Royaume-Uni] ; Eleni Maratos [Royaume-Uni] ; Peter Jenner [Royaume-Uni] | Effect of pulsatile administration of levodopa on dyskinesia induction in drug‐naïve MPTP‐treated common marmosets: Effect of dose, frequency of administration, and brain exposure |
| 001898 (2002) |
Werner Poewe [Autriche] ; G. Deuschl ; A. Gordin [Finlande] ; E. Kultalahti [Finlande] ; M. Leinonen [Finlande] | Efficacy and safety of entacapone in Parkinson's disease patients with suboptimal Levodopa response: a 6‐month randomized placebo‐controlled double‐blind study in Germany and Austria (Celomen study) |
| 001A00 (2001) |
V. V. Myllyl ; E. Kultalahti [Finlande] ; H. Haapaniemi [Finlande] ; M. Leinonen [Finlande] | Twelve‐month safety of entacapone in patients with Parkinson’s disease |
| 001A85 (2001) |
Hanna M. Ruottinen [Finlande] ; Mikko Niinivirta [Finlande] ; Jörgen Bergman [Finlande] ; Vesa Oikonen [Finlande] ; Olof Solin [Finlande] ; Olli Eskola [Finlande] ; Esa Eronen [Finlande] ; Pirkko Sonninen [Finlande] ; Urpo K. Rinne [Finlande] | Detection of response to COMT inhibition in FDOPA PET in advanced Parkinson's disease requires prolonged imaging |
| 001C57 (2000) |
Cheryl Waters [États-Unis] | Catechol‐O‐Methyltransferase (COMT) Inhibitors in Parkinson's Disease |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "entacapone"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i \
-Sk "entacapone" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Exploration
|type= indexItem
|index= KwdEn.i
|clé= entacapone
}}
| This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024 |  |
